Australian Healthtech Stock News

ASX:6KA
ASX:6KAMetals and Mining

6K Additive (ASX:6KA) Loss Deepens, Reinforcing Bearish Cash Runway and Balance Sheet Concerns

6K Additive (ASX:6KA) has released its H1 2025 numbers, posting total revenue of about $9.7 million alongside a net loss of roughly $12.8 million. This leaves investors weighing modest top line progress against ongoing red ink. The company has seen revenue move from around $7.7 million in H1 2024 to $9.7 million in H1 2025. Meanwhile, trailing 12 month revenue sits near $20.4 million against a net loss of about $26.6 million, underscoring a business that is expanding sales but still running...
ASX:SXE
ASX:SXEConstruction

Southern Cross Electrical Engineering (ASX:SXE): Revisiting Valuation After Heyday’s WestConnex Arbitration Loss

Southern Cross Electrical Engineering (ASX:SXE) is back on traders radar after its Heyday subsidiary lost an arbitration case over extra costs on the WestConnex M5 tunnel project, raising fresh questions about contract risk. See our latest analysis for Southern Cross Electrical Engineering. Despite the arbitration overhang, Southern Cross Electrical Engineering’s A$2.36 share price still reflects solid momentum. A 90 day share price return of 21.03 percent and a standout five year total...
ASX:HAV
ASX:HAVMetals and Mining

ASX Penny Stocks Spotlight: Havilah Resources And Two More To Consider

Australian shares are poised for a modest gain, though recent patterns suggest caution as investors react to market fluctuations. Despite the volatility, penny stocks—often smaller or newer companies—remain an intriguing investment area due to their affordability and potential for growth. When these stocks are supported by strong financial health, they can offer opportunities that defy traditional expectations.